Diplomat Pharmacy, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was USD 1,301.197 million compared to USD 1,373.334 million a year ago. Operating loss was USD 167.857 million compared to operating Income of USD 9.939 million a year ago. Net loss was USD 177.280 million compared to net income of USD 169,000 a year ago. Basic loss per share was USD 2.35. Basic loss per share from continuing operations was USD 2.35. For the nine months, sales was USD 3,845.629 million compared to USD 4,131.896 million a year ago. Operating loss was USD 320.464 million compared to operating Income of USD 26.448 million a year ago. Net loss was USD 351.043 million compared to USD 4.244 million a year ago. Basic loss per share was USD 4.69 compared to USD 0.06 a year ago.